Cargando…
Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788881/ https://www.ncbi.nlm.nih.gov/pubmed/30885995 http://dx.doi.org/10.1136/annrheumdis-2018-214860 |
| _version_ | 1783458541998178304 |
|---|---|
| author | Dervieux, Thierry Kremer, Joel M Weinblatt, Michael E |
| author_facet | Dervieux, Thierry Kremer, Joel M Weinblatt, Michael E |
| author_sort | Dervieux, Thierry |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6788881 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67888812019-10-25 Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept Dervieux, Thierry Kremer, Joel M Weinblatt, Michael E Ann Rheum Dis Letter BMJ Publishing Group 2019-09 2019-03-18 /pmc/articles/PMC6788881/ /pubmed/30885995 http://dx.doi.org/10.1136/annrheumdis-2018-214860 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Letter Dervieux, Thierry Kremer, Joel M Weinblatt, Michael E Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept |
| title | Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept |
| title_full | Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept |
| title_fullStr | Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept |
| title_full_unstemmed | Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept |
| title_short | Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept |
| title_sort | differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788881/ https://www.ncbi.nlm.nih.gov/pubmed/30885995 http://dx.doi.org/10.1136/annrheumdis-2018-214860 |
| work_keys_str_mv | AT dervieuxthierry differingcontributionofmethotrexatepolyglutamatestoadalimumabbloodlevelsascomparedwithetanercept AT kremerjoelm differingcontributionofmethotrexatepolyglutamatestoadalimumabbloodlevelsascomparedwithetanercept AT weinblattmichaele differingcontributionofmethotrexatepolyglutamatestoadalimumabbloodlevelsascomparedwithetanercept |